News
Our latest moves
All
Scientists turn to machine learning to tackle one of gene therapy’s biggest challenges
Press
Stat News
February 11, 2021
Scientists turn to machine learning to tackle one of gene therapy’s biggest challenges
Press
Stat News
February 11, 2021
Dyno, Roche to tackle CNS, liver disease in gene therapy deal worth up to $1.8B
Press
Fierce Biotech
October 14, 2020
Dyno, Roche to tackle CNS, liver disease in gene therapy deal worth up to $1.8B
Press
Fierce Biotech
October 14, 2020
Roche turns to a Harvard upstart out of George Church’s lab to construct AAV 2.0 model vectors — a key part of building the gene therapy pipeline
Press
Endpoints News
October 14, 2020
Roche turns to a Harvard upstart out of George Church’s lab to construct AAV 2.0 model vectors — a key part of building the gene therapy pipeline
Press
Endpoints News
October 14, 2020
Roche Enlists Dyno to Bring AI to NExt_Generation Liver, CNS Gene Therapies
Press
BioProcess International
October 14, 2020
Roche Enlists Dyno to Bring AI to NExt_Generation Liver, CNS Gene Therapies
Press
BioProcess International
October 14, 2020
Dyno Therapeutics Enters Collaboration and License Agreement with Roche to Develop Next-Generation AAV Gene Therapy Vectors for CNS Diseases and Liver-Directed Therapies
Announcements
October 14, 2020
Dyno Therapeutics Enters Collaboration and License Agreement with Roche to Develop Next-Generation AAV Gene Therapy Vectors for CNS Diseases and Liver-Directed Therapies
Announcements
October 14, 2020
AdaLead: A simple and robust adaptive greedy search algorithm for sequence design
Publications
Arxiv
October 5, 2020
AdaLead: A simple and robust adaptive greedy search algorithm for sequence design
Publications
Arxiv
October 5, 2020
Dyno Therapeutics Announces Exercise of Option by Roche for Next-Generation AAV Vector for Neurological Gene Therapy
Announcements
January 13, 2025
Dyno Therapeutics Announces Exercise of Option by Roche for Next-Generation AAV Vector for Neurological Gene Therapy
Announcements
January 13, 2025
Dyno Therapeutics to Accelerate Design of High-Performance Biological Sequences Using NVIDIA AI
Announcements
May 9, 2024
Dyno Therapeutics to Accelerate Design of High-Performance Biological Sequences Using NVIDIA AI
Announcements
May 9, 2024
Dyno Therapeutics Forms New Strategic Partnership With Roche To Advance AAV Gene Therapy Vectors For Neurological Diseases
Announcements
May 9, 2024
Dyno Therapeutics Forms New Strategic Partnership With Roche To Advance AAV Gene Therapy Vectors For Neurological Diseases
Announcements
May 9, 2024
Dyno Therapeutics Launches Dyno eCap 1™ Vector, a Field-Leading AAV Capsid for Eye Gene Therapies
Announcements
October 25, 2023
Dyno Therapeutics Launches Dyno eCap 1™ Vector, a Field-Leading AAV Capsid for Eye Gene Therapies
Announcements
October 25, 2023
Dyno Therapeutics Launches the Dyno bCap 1™ Capsid Product, a Breakthrough CNS Gene Delivery Vector Created with Generative Artificial Intelligence
Announcements
May 19, 2023
Dyno Therapeutics Launches the Dyno bCap 1™ Capsid Product, a Breakthrough CNS Gene Delivery Vector Created with Generative Artificial Intelligence
Announcements
May 19, 2023
Dyno Therapeutics Named on the Forbes List of America’s Best Startup Employers 2022
Announcements
March 11, 2022
Dyno Therapeutics Named on the Forbes List of America’s Best Startup Employers 2022
Announcements
March 11, 2022
Dyno Therapeutics Named Emerging Company of the Year at New England Venture Capital Association’s 2021 NEVY Awards
Announcements
December 6, 2021
Dyno Therapeutics Named Emerging Company of the Year at New England Venture Capital Association’s 2021 NEVY Awards
Announcements
December 6, 2021
Astellas and Dyno Therapeutics Announce Research Collaboration to Develop Next-Generation AAV Gene Therapy Vectors for Skeletal and Cardiac Muscle
Announcements
December 2, 2021
Astellas and Dyno Therapeutics Announce Research Collaboration to Develop Next-Generation AAV Gene Therapy Vectors for Skeletal and Cardiac Muscle
Announcements
December 2, 2021
Dyno Therapeutics to Present Breakthrough Data on AAV Gene Delivery to the CNS, Eye, and Muscle at the 28th Annual Meeting of the American Society of Gene & Cell Therapy
Events
April 28, 2025
Dyno Therapeutics to Present Breakthrough Data on AAV Gene Delivery to the CNS, Eye, and Muscle at the 28th Annual Meeting of the American Society of Gene & Cell Therapy
Events
April 28, 2025
Dyno Therapeutics to Present on Breakthroughs in AI Methods for AAV Capsid Design at ASGCT Annual Meeting and SynBioBeta Global Synthetic Biology Conference
Events
April 23, 2024
Dyno Therapeutics to Present on Breakthroughs in AI Methods for AAV Capsid Design at ASGCT Annual Meeting and SynBioBeta Global Synthetic Biology Conference
Events
April 23, 2024
Dyno Therapeutics to Present on Breakthrough Optimized AAV Capsids for Eye and CNS Gene Delivery at ESGCT Annual Congress
Events
October 11, 2023
Dyno Therapeutics to Present on Breakthrough Optimized AAV Capsids for Eye and CNS Gene Delivery at ESGCT Annual Congress
Events
October 11, 2023
Dyno Therapeutics to Present New Data on Optimized AAV Capsids with Transformative Therapeutic Delivery Potential at 2023 Annual Meeting of the American Society of Gene & Cell Therapy (ASGCT)
Events
May 2, 2023
Dyno Therapeutics to Present New Data on Optimized AAV Capsids with Transformative Therapeutic Delivery Potential at 2023 Annual Meeting of the American Society of Gene & Cell Therapy (ASGCT)
Events
May 2, 2023
Dyno Therapeutics at Goldman Sachs Byte-ology Conference
Events
December 9, 2021
Dyno Therapeutics at Goldman Sachs Byte-ology Conference
Events
December 9, 2021
Dyno Therapeutics Presents State-of-the-Art Applications of Machine Learning to Design Improved AAV Capsids for a Broad Range of Gene Therapies at American Society of Gene and Cell Therapy Conference
Events
May 11, 2021
Dyno Therapeutics Presents State-of-the-Art Applications of Machine Learning to Design Improved AAV Capsids for a Broad Range of Gene Therapies at American Society of Gene and Cell Therapy Conference
Events
May 11, 2021
Low-N OpenFold fine-tuning improves peptide design without additional structures
Publications
NeurIPS MLSB
October 4, 2024
Low-N OpenFold fine-tuning improves peptide design without additional structures
Publications
NeurIPS MLSB
October 4, 2024
Contrastive losses as generalized models of global epistasis
Publications
38th Conference on Neural Information Processing Systems
May 1, 2024
Contrastive losses as generalized models of global epistasis
Publications
38th Conference on Neural Information Processing Systems
May 1, 2024
Bionemo Framework: A Modular, High-Performance Library For AI Model Development In Drug Discovery
Publications
Arxiv
May 1, 2024
Bionemo Framework: A Modular, High-Performance Library For AI Model Development In Drug Discovery
Publications
Arxiv
May 1, 2024
Beyond the training set: an intuitive method for detecting distribution shift in model-based optimization
Publications
Arxiv
November 9, 2023
Beyond the training set: an intuitive method for detecting distribution shift in model-based optimization
Publications
Arxiv
November 9, 2023
Generative design for gene therapy: An in vivo validated method
Publications
NeurIPS GenBio
October 27, 2023
Generative design for gene therapy: An in vivo validated method
Publications
NeurIPS GenBio
October 27, 2023
Forecasting labels under distribution-shift for machine-guided sequence design
Publications
PMLR
August 3, 2023
Forecasting labels under distribution-shift for machine-guided sequence design
Publications
PMLR
August 3, 2023
Giant steps: Dyno closes $100M series A round for advanced capsid engineering
Press
BioWorld
May 6, 2021
Giant steps: Dyno closes $100M series A round for advanced capsid engineering
Press
BioWorld
May 6, 2021
Dyno raises $100 million to bring artificial intelligence to gene therapy
Press
Boston Globe
May 5, 2021
Dyno raises $100 million to bring artificial intelligence to gene therapy
Press
Boston Globe
May 5, 2021
The 20(+1) under 40: Inside the next generation of biotech leaders
Press
Endpoints News
April 6, 2021
The 20(+1) under 40: Inside the next generation of biotech leaders
Press
Endpoints News
April 6, 2021
AI Generates Unprecedented Diversity of AAV Capsids
Press
Gen Eng News
February 12, 2021
AI Generates Unprecedented Diversity of AAV Capsids
Press
Gen Eng News
February 12, 2021
Scientists turn to machine learning to tackle one of gene therapy’s biggest challenges
Press
Stat News
February 11, 2021
Scientists turn to machine learning to tackle one of gene therapy’s biggest challenges
Press
Stat News
February 11, 2021
Dyno sketches tens of thousands of viable next-gen AAV capsids with the help of machine learning — paper
Press
Endpoints News
February 11, 2021
Dyno sketches tens of thousands of viable next-gen AAV capsids with the help of machine learning — paper
Press
Endpoints News
February 11, 2021